Strengthening the reporting of genetic risk prediction studies (GRIPS)

Explanation and elaboration

A. Cecile J W Janssens, John P A Ioannidis, Sara Bedrosian, Paolo Boffetta, Siobhan M. Dolan, Nicole Dowling, Isabel Fortier, Andrew N. Freedman, Jeremy M. Grimshaw, Jeffrey Gulcher, Marta Gwinn, Mark A. Hlatky, Holly Janes, Peter Kraft, Stephanie Melillo, Christopher J. O'donnell, Michael J. Pencina, David Ransohoff, Sheri D. Schully, Daniela Seminara & 5 others Deborah M. Winn, Caroline F. Wright, Cornelia M. Van Duijn, Julian Little, Muin J. Khoury

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The rapid and continuing progress in gene discovery for complex diseases is fuelling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies assessing the predictive ability is steadily increasing, but they vary widely in completeness of reporting and apparent quality. Transparent reporting of the strengths and weaknesses of these studies is important to facilitate the accumulation of evidence on genetic risk prediction. A multidisciplinary workshop sponsored by the Human Genome Epidemiology Network developed a checklist of 25 items recommended for strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS), building on the principles established by prior reporting guidelines. These recommendations aim to enhance the transparency, quality and completeness of study reporting and thereby to improve the synthesis and application of information from multiple studies that might differ in design, conduct or analysis.

Original languageEnglish (US)
Pages (from-to)1010-1035
Number of pages26
JournalEuropean Journal of Clinical Investigation
Volume41
Issue number9
DOIs
StatePublished - Sep 2011

Fingerprint

Genes
Public Health Practice
Epidemiology
Fueling
Genetic Models
Genetic Association Studies
Public health
Human Genome
Checklist
Transparency
Guidelines
Education

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry
  • Biochemistry

Cite this

Strengthening the reporting of genetic risk prediction studies (GRIPS) : Explanation and elaboration. / Janssens, A. Cecile J W; Ioannidis, John P A; Bedrosian, Sara; Boffetta, Paolo; Dolan, Siobhan M.; Dowling, Nicole; Fortier, Isabel; Freedman, Andrew N.; Grimshaw, Jeremy M.; Gulcher, Jeffrey; Gwinn, Marta; Hlatky, Mark A.; Janes, Holly; Kraft, Peter; Melillo, Stephanie; O'donnell, Christopher J.; Pencina, Michael J.; Ransohoff, David; Schully, Sheri D.; Seminara, Daniela; Winn, Deborah M.; Wright, Caroline F.; Van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.

In: European Journal of Clinical Investigation, Vol. 41, No. 9, 09.2011, p. 1010-1035.

Research output: Contribution to journalArticle

Janssens, ACJW, Ioannidis, JPA, Bedrosian, S, Boffetta, P, Dolan, SM, Dowling, N, Fortier, I, Freedman, AN, Grimshaw, JM, Gulcher, J, Gwinn, M, Hlatky, MA, Janes, H, Kraft, P, Melillo, S, O'donnell, CJ, Pencina, MJ, Ransohoff, D, Schully, SD, Seminara, D, Winn, DM, Wright, CF, Van Duijn, CM, Little, J & Khoury, MJ 2011, 'Strengthening the reporting of genetic risk prediction studies (GRIPS): Explanation and elaboration', European Journal of Clinical Investigation, vol. 41, no. 9, pp. 1010-1035. https://doi.org/10.1111/j.1365-2362.2011.02493.x
Janssens, A. Cecile J W ; Ioannidis, John P A ; Bedrosian, Sara ; Boffetta, Paolo ; Dolan, Siobhan M. ; Dowling, Nicole ; Fortier, Isabel ; Freedman, Andrew N. ; Grimshaw, Jeremy M. ; Gulcher, Jeffrey ; Gwinn, Marta ; Hlatky, Mark A. ; Janes, Holly ; Kraft, Peter ; Melillo, Stephanie ; O'donnell, Christopher J. ; Pencina, Michael J. ; Ransohoff, David ; Schully, Sheri D. ; Seminara, Daniela ; Winn, Deborah M. ; Wright, Caroline F. ; Van Duijn, Cornelia M. ; Little, Julian ; Khoury, Muin J. / Strengthening the reporting of genetic risk prediction studies (GRIPS) : Explanation and elaboration. In: European Journal of Clinical Investigation. 2011 ; Vol. 41, No. 9. pp. 1010-1035.
@article{fdeddfa5734b421a815098695cfd8583,
title = "Strengthening the reporting of genetic risk prediction studies (GRIPS): Explanation and elaboration",
abstract = "The rapid and continuing progress in gene discovery for complex diseases is fuelling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies assessing the predictive ability is steadily increasing, but they vary widely in completeness of reporting and apparent quality. Transparent reporting of the strengths and weaknesses of these studies is important to facilitate the accumulation of evidence on genetic risk prediction. A multidisciplinary workshop sponsored by the Human Genome Epidemiology Network developed a checklist of 25 items recommended for strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS), building on the principles established by prior reporting guidelines. These recommendations aim to enhance the transparency, quality and completeness of study reporting and thereby to improve the synthesis and application of information from multiple studies that might differ in design, conduct or analysis.",
author = "Janssens, {A. Cecile J W} and Ioannidis, {John P A} and Sara Bedrosian and Paolo Boffetta and Dolan, {Siobhan M.} and Nicole Dowling and Isabel Fortier and Freedman, {Andrew N.} and Grimshaw, {Jeremy M.} and Jeffrey Gulcher and Marta Gwinn and Hlatky, {Mark A.} and Holly Janes and Peter Kraft and Stephanie Melillo and O'donnell, {Christopher J.} and Pencina, {Michael J.} and David Ransohoff and Schully, {Sheri D.} and Daniela Seminara and Winn, {Deborah M.} and Wright, {Caroline F.} and {Van Duijn}, {Cornelia M.} and Julian Little and Khoury, {Muin J.}",
year = "2011",
month = "9",
doi = "10.1111/j.1365-2362.2011.02493.x",
language = "English (US)",
volume = "41",
pages = "1010--1035",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Strengthening the reporting of genetic risk prediction studies (GRIPS)

T2 - Explanation and elaboration

AU - Janssens, A. Cecile J W

AU - Ioannidis, John P A

AU - Bedrosian, Sara

AU - Boffetta, Paolo

AU - Dolan, Siobhan M.

AU - Dowling, Nicole

AU - Fortier, Isabel

AU - Freedman, Andrew N.

AU - Grimshaw, Jeremy M.

AU - Gulcher, Jeffrey

AU - Gwinn, Marta

AU - Hlatky, Mark A.

AU - Janes, Holly

AU - Kraft, Peter

AU - Melillo, Stephanie

AU - O'donnell, Christopher J.

AU - Pencina, Michael J.

AU - Ransohoff, David

AU - Schully, Sheri D.

AU - Seminara, Daniela

AU - Winn, Deborah M.

AU - Wright, Caroline F.

AU - Van Duijn, Cornelia M.

AU - Little, Julian

AU - Khoury, Muin J.

PY - 2011/9

Y1 - 2011/9

N2 - The rapid and continuing progress in gene discovery for complex diseases is fuelling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies assessing the predictive ability is steadily increasing, but they vary widely in completeness of reporting and apparent quality. Transparent reporting of the strengths and weaknesses of these studies is important to facilitate the accumulation of evidence on genetic risk prediction. A multidisciplinary workshop sponsored by the Human Genome Epidemiology Network developed a checklist of 25 items recommended for strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS), building on the principles established by prior reporting guidelines. These recommendations aim to enhance the transparency, quality and completeness of study reporting and thereby to improve the synthesis and application of information from multiple studies that might differ in design, conduct or analysis.

AB - The rapid and continuing progress in gene discovery for complex diseases is fuelling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies assessing the predictive ability is steadily increasing, but they vary widely in completeness of reporting and apparent quality. Transparent reporting of the strengths and weaknesses of these studies is important to facilitate the accumulation of evidence on genetic risk prediction. A multidisciplinary workshop sponsored by the Human Genome Epidemiology Network developed a checklist of 25 items recommended for strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS), building on the principles established by prior reporting guidelines. These recommendations aim to enhance the transparency, quality and completeness of study reporting and thereby to improve the synthesis and application of information from multiple studies that might differ in design, conduct or analysis.

UR - http://www.scopus.com/inward/record.url?scp=79960971848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960971848&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2011.02493.x

DO - 10.1111/j.1365-2362.2011.02493.x

M3 - Article

VL - 41

SP - 1010

EP - 1035

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 9

ER -